chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Urticaria, Vaccination complication
Clinical narrative: Inflammation on her right side; Redness on her right side and leg; Hives; Chills; Temperature of just over 100 degrees F; Mild reaction at the time; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Mild reaction at the time), INFLAMMATION (Inflammation on her right side), ERYTHEMA (Redness on her right side and leg), URTICARIA (Hives) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION COMPLICATION (Mild reaction at the time). On 07-Mar-2021, the patient experienced INFLAMMATION (Inflammation on her right side), ERYTHEMA (Redness on her right side and leg), URTICARIA (Hives), CHILLS (Chills) and PYREXIA (Temperature of just over 100 degrees F). On 19-Feb-2021, VACCINATION COMPLICATION (Mild reaction at the time) had resolved. At the time of the report, INFLAMMATION (Inflammation on her right side), ERYTHEMA (Redness on her right side and leg), URTICARIA (Hives), CHILLS (Chills) and PYREXIA (Temperature of just over 100 degrees F) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, Body temperature: high (High) Temperature of just over 100 degrees F.         Concomitant product use was not provided by the reporter.  No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: fever; chills; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) for Fever and Pain, at an unspecified dose and frequency. At the time of the report, PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided  by the reporter.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia
Clinical narrative: Achey all over; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Achey all over), CHILLS (Chills) and HEADACHE (Headache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 043L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure. Concomitant products included VITAMINS NOS and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced MYALGIA (Achey all over), CHILLS (Chills) and HEADACHE (Headache). At the time of the report, MYALGIA (Achey all over), CHILLS (Chills) and HEADACHE (Headache) had not resolved.            Action taken with mRNA-1273 in response to the events was not applicable. Concomitant medication included unspecified Blood Pressure medications. No treatment medication details was reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hyperhidrosis, Pain in extremity
Clinical narrative: Sore arm; Slight headache; Chills; Low grade fever; Sweats; Still a little tender; Exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), HYPERHIDROSIS (Sweats), TENDERNESS (Still a little tender), FATIGUE (Exhaustion) and HEADACHE (Slight headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.  Concomitant products included METOPROLOL and APIXABAN (ELIQUIS) for an unknown indication.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced HYPERHIDROSIS (Sweats), TENDERNESS (Still a little tender), FATIGUE (Exhaustion) and PYREXIA (Low grade fever). On 09-Feb-2021, the patient experienced CHILLS (Chills). On 11-Feb-2021, the patient experienced HEADACHE (Slight headache). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 09-Feb-2021, HYPERHIDROSIS (Sweats), FATIGUE (Exhaustion), CHILLS (Chills) and PYREXIA (Low grade fever) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown and TENDERNESS (Still a little tender) and HEADACHE (Slight headache) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-033561 (Patient Link).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tenderness
Clinical narrative: Sore arm; Slight headache; Chills; Low grade fever; Sweats; Still a little tender; Exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), HYPERHIDROSIS (Sweats), TENDERNESS (Still a little tender), FATIGUE (Exhaustion) and HEADACHE (Slight headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.  Concomitant products included METOPROLOL and APIXABAN (ELIQUIS) for an unknown indication.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced HYPERHIDROSIS (Sweats), TENDERNESS (Still a little tender), FATIGUE (Exhaustion) and PYREXIA (Low grade fever). On 09-Feb-2021, the patient experienced CHILLS (Chills). On 11-Feb-2021, the patient experienced HEADACHE (Slight headache). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 09-Feb-2021, HYPERHIDROSIS (Sweats), FATIGUE (Exhaustion), CHILLS (Chills) and PYREXIA (Low grade fever) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown and TENDERNESS (Still a little tender) and HEADACHE (Slight headache) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-033561 (Patient Link).
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling at the injection site) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE SWELLING (Swelling at the injection site). At the time of the report, VACCINATION SITE SWELLING (Swelling at the injection site) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medication details was reported. No treatment medication details was reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Ttingling that went up her neck on left side of face; Numbness; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Ttingling that went up her neck on left side of face) and HYPOAESTHESIA (Numbness) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 024M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included APIXABAN (ELIQUIS), DIGOXIN, PRAVASTATIN and DILTIAZEM for an unknown indication.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced PARAESTHESIA (Ttingling that went up her neck on left side of face). 13-Mar-2021, the patient experienced HYPOAESTHESIA (Numbness). On 13-Mar-2021, PARAESTHESIA (Ttingling that went up her neck on left side of face) and HYPOAESTHESIA (Numbness) had resolved.            Action taken with mRNA-1273 in response to the events was not applicable. No treatment medication details was reported.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Exposure via breast milk
Clinical narrative: breastfeeding twice a day; dizziness; This spontaneous case was reported by a nurse and describes the occurrence of EXPOSURE VIA BREAST MILK (breastfeeding twice a day) and DIZZINESS (dizziness) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 07-Feb-2021, the patient experienced DIZZINESS (dizziness). On an unknown date, the patient experienced EXPOSURE VIA BREAST MILK (breastfeeding twice a day). At the time of the report, EXPOSURE VIA BREAST MILK (breastfeeding twice a day) and DIZZINESS (dizziness) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.    Treatment information was not provided by the reporter Action taken with mRNA-1273 in response to the events  was not applicable.   This case was linked to MOD-2021-017385.   See case MOD-2021-017385 for details regarding the child case.
Sex: U
Vaccine: COVID19
Symptoms: Energy increased, Paraesthesia
Clinical narrative: felt tinggling on tongue and jaw; Came home feeling with alot of energy; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (felt tinggling on tongue and jaw) and ENERGY INCREASED (Came home feeling with alot of energy) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PARAESTHESIA (felt tinggling on tongue and jaw) and ENERGY INCREASED (Came home feeling with alot of energy). At the time of the report, PARAESTHESIA (felt tinggling on tongue and jaw) had resolved and ENERGY INCREASED (Came home feeling with alot of energy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications was reported Treatment information was not provided
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Itchy hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Itchy hives) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) unknown. On 10-Mar-2021, the patient experienced URTICARIA (Itchy hives). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Hives, at a dose of UNK dosage form. At the time of the report, URTICARIA (Itchy hives) had not resolved.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose increased, Chills, Fatigue
Clinical narrative: Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and FATIGUE (Fatigue) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Thyroid disorder NOS and Hypercholesteremia. Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID], NITROGLYCERIN, MAGNESIUM and VITAMIN B NOS (B-COMPLEX [VITAMIN B NOS]) for an unknown indication.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, CHILLS (Chills) and FATIGUE (Fatigue) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Mar-2021, Blood glucose increased: 191 (High) Usually 125-133  every morning..         Action taken with mRNA-1273 in response to the events was not applicable. No treatment medication details was reported.
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Mobility decreased, Pain in extremity
Clinical narrative: Severe pain in  armpit area and left arm; Warming sensation; Can't lift arm,Can't even lift a cup of coffee; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Severe pain in  armpit area and left arm), FEELING HOT (Warming sensation) and MOBILITY DECREASED (Can't lift arm,Can't even lift a cup of coffee) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 01221) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (Severe pain in  armpit area and left arm), FEELING HOT (Warming sensation) and MOBILITY DECREASED (Can't lift arm,Can't even lift a cup of coffee). The patient was treated with IBUPROFEN for Pain, at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (Severe pain in  armpit area and left arm) had not resolved and FEELING HOT (Warming sensation) and MOBILITY DECREASED (Can't lift arm,Can't even lift a cup of coffee) outcome was unknown.            No Concomitant medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: fever of 101 degrees Fahrenheit; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 101 degrees Fahrenheit) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced PYREXIA (fever of 101 degrees Fahrenheit). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 15-Mar-2021, PYREXIA (fever of 101 degrees Fahrenheit) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Mar-2021, Body temperature: 101 (High) 101 degrees F usual temperature is 97.6 degrees F.         Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medication details was reported.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity
Clinical narrative: Severe headache when tried to think; Tiredness; Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness), PAIN IN EXTREMITY (Arm soreness) and HEADACHE (Severe headache when tried to think) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Antihistamine therapy, ATORVASTATIN CALCIUM (LIPITOR) for Cholesterol.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced FATIGUE (Tiredness) and PAIN IN EXTREMITY (Arm soreness). On 14-Mar-2021, the patient experienced HEADACHE (Severe headache when tried to think). At the time of the report, FATIGUE (Tiredness), PAIN IN EXTREMITY (Arm soreness) and HEADACHE (Severe headache when tried to think) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication not reported.  The patient stated that they have three other prescription medicine that he's taking daily.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased, Palpitations
Clinical narrative: "heart banging against my chest"; Heart rate of 110bpm; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS ("heart banging against my chest") and HEART RATE INCREASED (Heart rate of 110bpm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PALPITATIONS ("heart banging against my chest") and HEART RATE INCREASED (Heart rate of 110bpm). On 26-Feb-2021, PALPITATIONS ("heart banging against my chest") and HEART RATE INCREASED (Heart rate of 110bpm) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Heart rate: 110 (High) 110 beats per minutes.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication provided. No concomitant medication provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow-up information received on 25-MAY-2021 and contains no new information.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia
Clinical narrative: body aches; fever; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), PYREXIA (fever) and FATIGUE (fatigue) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Enlarged prostate. Concomitant products included MONTELUKAST and FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for Asthma, TAMSULOSIN for Enlarged prostate, NAPROXEN for an unknown indication.   On 27-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (body aches), PYREXIA (fever) and FATIGUE (fatigue). At the time of the report, PAIN (body aches), PYREXIA (fever) and FATIGUE (fatigue) outcome was unknown.            No treatment medication details was reported.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Vaccination site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: inflammation inside the arm pit; warmth at injection site; pain at the injection site; injection site is even more red; This spontaneous case was reported by a health care professional and describes the occurrence of INFLAMMATION (inflammation inside the arm pit), VACCINATION SITE WARMTH (warmth at injection site), VACCINATION SITE PAIN (pain at the injection site) and VACCINATION SITE ERYTHEMA (injection site is even more red) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE WARMTH (warmth at injection site), VACCINATION SITE PAIN (pain at the injection site) and VACCINATION SITE ERYTHEMA (injection site is even more red). On 05-Mar-2021, the patient experienced INFLAMMATION (inflammation inside the arm pit). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of UNK dosage form. On 05-Mar-2021, VACCINATION SITE WARMTH (warmth at injection site) and VACCINATION SITE PAIN (pain at the injection site) had resolved. At the time of the report, INFLAMMATION (inflammation inside the arm pit) outcome was unknown and VACCINATION SITE ERYTHEMA (injection site is even more red) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medication was reported.
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose
Clinical narrative: vaccine came out on their arm; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL UNDERDOSE (vaccine came out on their arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced ACCIDENTAL UNDERDOSE (vaccine came out on their arm). On 14-Mar-2021, ACCIDENTAL UNDERDOSE (vaccine came out on their arm) had resolved. Not Provided          No concomitant medications reported by reporter. Treatment medication was not reported. Action taken with mRNA-1273 was not applicable.   Reporter did not allow further contact
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Ultrasound antenatal screen normal
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 33-year-old female patient (gravida 3, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 027B21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Allergy to antibiotic (sulfa antibiotics). Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for Prenatal care, COLECALCIFEROL, MENAQUINONE-7, PHYTOMENADIONE, RETINOL PALMITATE, TOCOPHEROL, TOCOTRIENOLS NOS (VITAMIN D COMPLEX) for an unknown indication.   On 12-Mar-2021 at 4:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 06-Oct-2021. On 12-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). On 12-Mar-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Feb-2021, Ultrasound antenatal screen normal: normal (normal) normal.         Treatment information was not provided. Laboratory information included NIPT test in 2021 on an unknown date, the findings are normal/ no abnormalities, female. Previous pregnancy end dates 25 MAY 2016 and 17 DEC 2018, with live birth as an outcome.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Pregnancy form attached; additional lab data reported.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Vertigo
Clinical narrative: Vertigo; Ear Ache; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo) and EAR PAIN (Ear Ache) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced VERTIGO (Vertigo) and EAR PAIN (Ear Ache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 15-Mar-2021, VERTIGO (Vertigo) and EAR PAIN (Ear Ache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash erythematous, Vaccination site pain, Vaccination site rash, Vaccination site warmth
Clinical narrative: Kind of warm to touch; "rash at the site of injection about 2/1 in; rash at the site of injection about 2/1 in" and "kind of warm to touch", "tender"; Normal sore arm; Red rash around side area; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Normal sore arm), RASH ERYTHEMATOUS (Red rash around side area), VACCINATION SITE WARMTH (Kind of warm to touch), VACCINATION SITE RASH ("rash at the site of injection about 2/1 in) and VACCINATION SITE PAIN (rash at the site of injection about 2/1 in" and "kind of warm to touch", "tender") in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Overweight and Blood pressure (Blood pressure is high.).    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (Normal sore arm) and RASH ERYTHEMATOUS (Red rash around side area). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Kind of warm to touch), VACCINATION SITE RASH ("rash at the site of injection about 2/1 in) and VACCINATION SITE PAIN (rash at the site of injection about 2/1 in" and "kind of warm to touch", "tender"). At the time of the report, PAIN IN EXTREMITY (Normal sore arm), RASH ERYTHEMATOUS (Red rash around side area), VACCINATION SITE WARMTH (Kind of warm to touch), VACCINATION SITE RASH ("rash at the site of injection about 2/1 in) and VACCINATION SITE PAIN (rash at the site of injection about 2/1 in" and "kind of warm to touch", "tender") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included pills for overweight, high blood pressure Treatment information was not provided
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Nausea, Pain, Vomiting
Clinical narrative: nausea; vomiting; chills; achy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achy), NAUSEA (nausea), VOMITING (vomiting) and CHILLS (chills) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 12-Mar-2021, the patient experienced PAIN (achy). On 13-Mar-2021, the patient experienced NAUSEA (nausea), VOMITING (vomiting) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (achy), NAUSEA (nausea), VOMITING (vomiting) and CHILLS (chills) had not resolved.            No relevant concomitant medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Myalgia, Pain in extremity, Pyrexia, Vaccination site pain
Clinical narrative: pain when lifting left arm; Fever; body aches and pain; Injection site tenderness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain when lifting left arm), PYREXIA (Fever), MYALGIA (body aches and pain) and VACCINATION SITE PAIN (Injection site tenderness) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021 at 9:50 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain when lifting left arm), PYREXIA (Fever), MYALGIA (body aches and pain) and VACCINATION SITE PAIN (Injection site tenderness). On 15-Mar-2021, PAIN IN EXTREMITY (pain when lifting left arm), PYREXIA (Fever), MYALGIA (body aches and pain) and VACCINATION SITE PAIN (Injection site tenderness) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Mar-2021, Body temperature: 99.7 (High) 99.7 degree F.         Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medication details was reported. No treatment medication details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Updated first dose information and changed event outcome from unknown to recovered/resolved.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash, Rash erythematous
Clinical narrative: Bright red spot on both her feet and ankles; rash on arm, faint redness and bright red spot on both her feet and ankles; Itching; Faint redness; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching), ERYTHEMA (Faint redness), RASH ERYTHEMATOUS (Bright red spot on both her feet and ankles) and RASH (rash on arm, faint redness and bright red spot on both her feet and ankles) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     Concomitant products included METFORMIN, AMLODIPINE BESILATE, BENAZEPRIL HYDROCHLORIDE (AMLODIPINE BENAZEPRIL), ESZOPICLONE, ARIPIPRAZOLE and SERTRALINE HYDROCHLORIDE (SERTRALINE [SERTRALINE HYDROCHLORIDE]) for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PRURITUS (Itching), ERYTHEMA (Faint redness) and RASH (rash on arm, faint redness and bright red spot on both her feet and ankles). On 13-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Bright red spot on both her feet and ankles). At the time of the report, PRURITUS (Itching), ERYTHEMA (Faint redness), RASH ERYTHEMATOUS (Bright red spot on both her feet and ankles) and RASH (rash on arm, faint redness and bright red spot on both her feet and ankles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information reported
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: tested positive after first dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive after first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced COVID-19 (tested positive after first dose). At the time of the report, COVID-19 (tested positive after first dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment information was provided.   This case was linked to MOD-2021-044179 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Follow-up information received on 21-MAY-2021 and contains no new information.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Swelling under the left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling under the left arm) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Swelling under the left arm). At the time of the report, VACCINATION SITE SWELLING (Swelling under the left arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was reported.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: slight puffiness at the injection site; soreness at the injection site/tenderness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (slight puffiness at the injection site) and VACCINATION SITE PAIN (soreness at the injection site/tenderness at the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013821A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE SWELLING (slight puffiness at the injection site) and VACCINATION SITE PAIN (soreness at the injection site/tenderness at the injection site). At the time of the report, VACCINATION SITE SWELLING (slight puffiness at the injection site) and VACCINATION SITE PAIN (soreness at the injection site/tenderness at the injection site) outcome was unknown.            No Concomitant medications were provided. No Treatments were provided.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 03-Feb-2021, PAIN IN EXTREMITY (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided. No Treatments were provided.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Rash
Clinical narrative: (rash with) Blisters; Rash from head to toe/Rash covered whole body; This spontaneous case was reported by a pharmacist and describes the occurrence of BLISTER ((rash with) Blisters) and RASH (Rash from head to toe/Rash covered whole body) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced BLISTER ((rash with) Blisters) and RASH (Rash from head to toe/Rash covered whole body). At the time of the report, BLISTER ((rash with) Blisters) and RASH (Rash from head to toe/Rash covered whole body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitants were provided. No treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose decreased, Blood glucose increased, Tremor, Vaccination complication
Clinical narrative: Legs shaking; Adverse effect; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Legs shaking) and VACCINATION COMPLICATION (Adverse effect) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 003A21A) for COVID-19 vaccination.     The patient's past medical history included Unstable angina on 07-Mar-2021 and Kidney transplant in 2017. Concurrent medical conditions included Type 2 diabetes mellitus since 2007, Glaucoma since 2011, Hypertension since 2011 and Hyperthyroidism since 2018. Concomitant products included LABETALOL HYDROCHLORIDE (LABETOL) for Hypertension, TACROLIMUS from 2001 to an unknown date and PREDNISONE from 2001 to an unknown date for Kidney transplant rejection, METHIMAZOLE for Thyroid disorder, SIMVASTATIN for an unknown indication.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TREMOR (Legs shaking) and VACCINATION COMPLICATION (Adverse effect). At the time of the report, TREMOR (Legs shaking) and VACCINATION COMPLICATION (Adverse effect) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Mar-2021, Blood glucose decreased: 146 (Low) Decreased. On 13-Mar-2021, Blood glucose increased: 246 (High) Increased.     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment medications were unknown.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow-up information received on 07-MAY-2021 contains significant information: Added Patient's demographics, medical history and concomitant drugs.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Burning sensation, Fatigue, Feeling hot
Clinical narrative: Muscle pain; finger joints had Burning sensation/extreme joint pain in fingers and knees; Fingers so stiff can not bend them; Horrible back pain; Severe headache; legs felt weak and shaky; Injection site swollen; Injection site sore; Fatigue; feeling hot/knees were warm to touch; burning sensation; neck pain; super congestion; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle pain), ARTHRALGIA (finger joints had Burning sensation/extreme joint pain in fingers and knees), MUSCULOSKELETAL STIFFNESS (Fingers so stiff can not bend them), BACK PAIN (Horrible back pain) and HEADACHE (Severe headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension. Concomitant products included LISINOPRIL for Hypertension, ASCORBIC ACID (VIT C), COLECALCIFEROL (VIT D3), ZINC, IRON, B-COMPLEX [CALCIUM PANTOTHENATE;CYANOCOBALAMIN;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RIBOFLAVIN;THIAMINE MONONITRATE] and MULTI VIT for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced MYALGIA (Muscle pain), ARTHRALGIA (finger joints had Burning sensation/extreme joint pain in fingers and knees), MUSCULOSKELETAL STIFFNESS (Fingers so stiff can not bend them), BACK PAIN (Horrible back pain), HEADACHE (Severe headache), MUSCULAR WEAKNESS (legs felt weak and shaky), INJECTION SITE SWELLING (Injection site swollen), INJECTION SITE PAIN (Injection site sore), FATIGUE (Fatigue), FEELING HOT (feeling hot/knees were warm to touch), BURNING SENSATION (burning sensation), NECK PAIN (neck pain) and NASAL CONGESTION (super congestion). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form and IBUPROFEN at a dose of UNK dosage form. On 08-Feb-2021, MYALGIA (Muscle pain), BACK PAIN (Horrible back pain), HEADACHE (Severe headache), MUSCULAR WEAKNESS (legs felt weak and shaky), INJECTION SITE SWELLING (Injection site swollen), INJECTION SITE PAIN (Injection site sore), FATIGUE (Fatigue), FEELING HOT (feeling hot/knees were warm to touch), NECK PAIN (neck pain) and NASAL CONGESTION (super congestion) had resolved. On 15-Feb-2021, ARTHRALGIA (finger joints had Burning sensation/extreme joint pain in fingers and knees), MUSCULOSKELETAL STIFFNESS (Fingers so stiff can not bend them) and BURNING SENSATION (burning sensation) had resolved.            Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: additional information included email, medical history, patient information, concomitant medications  and significant events.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Injection site swelling, Muscular weakness, Musculoskeletal stiffness
Clinical narrative: Muscle pain; finger joints had Burning sensation/extreme joint pain in fingers and knees; Fingers so stiff can not bend them; Horrible back pain; Severe headache; legs felt weak and shaky; Injection site swollen; Injection site sore; Fatigue; feeling hot/knees were warm to touch; burning sensation; neck pain; super congestion; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle pain), ARTHRALGIA (finger joints had Burning sensation/extreme joint pain in fingers and knees), MUSCULOSKELETAL STIFFNESS (Fingers so stiff can not bend them), BACK PAIN (Horrible back pain) and HEADACHE (Severe headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension. Concomitant products included LISINOPRIL for Hypertension, ASCORBIC ACID (VIT C), COLECALCIFEROL (VIT D3), ZINC, IRON, B-COMPLEX [CALCIUM PANTOTHENATE;CYANOCOBALAMIN;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RIBOFLAVIN;THIAMINE MONONITRATE] and MULTI VIT for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced MYALGIA (Muscle pain), ARTHRALGIA (finger joints had Burning sensation/extreme joint pain in fingers and knees), MUSCULOSKELETAL STIFFNESS (Fingers so stiff can not bend them), BACK PAIN (Horrible back pain), HEADACHE (Severe headache), MUSCULAR WEAKNESS (legs felt weak and shaky), INJECTION SITE SWELLING (Injection site swollen), INJECTION SITE PAIN (Injection site sore), FATIGUE (Fatigue), FEELING HOT (feeling hot/knees were warm to touch), BURNING SENSATION (burning sensation), NECK PAIN (neck pain) and NASAL CONGESTION (super congestion). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form and IBUPROFEN at a dose of UNK dosage form. On 08-Feb-2021, MYALGIA (Muscle pain), BACK PAIN (Horrible back pain), HEADACHE (Severe headache), MUSCULAR WEAKNESS (legs felt weak and shaky), INJECTION SITE SWELLING (Injection site swollen), INJECTION SITE PAIN (Injection site sore), FATIGUE (Fatigue), FEELING HOT (feeling hot/knees were warm to touch), NECK PAIN (neck pain) and NASAL CONGESTION (super congestion) had resolved. On 15-Feb-2021, ARTHRALGIA (finger joints had Burning sensation/extreme joint pain in fingers and knees), MUSCULOSKELETAL STIFFNESS (Fingers so stiff can not bend them) and BURNING SENSATION (burning sensation) had resolved.            Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: additional information included email, medical history, patient information, concomitant medications  and significant events.